BPC-157

Your body has a repair system. BPC-157 activates it.

Recovery isn't just about rest — it's about signalling. BPC-157 is a peptide derived from a naturally occurring gastric protein, studied extensively for its role in telling the body where to direct its repair resources. Tendons, ligaments, muscle tissue, gut lining — BPC-157 works across all of them.

Why BPC-157 belongs in your recovery stack

Most people accept slow recovery as normal. Injuries that linger for months. Gut issues that never fully resolve. Soft tissue that breaks down faster than it rebuilds. The reality is that conventional recovery — rest, ice, physio, time — addresses the symptom, not the signal.

Your body's repair process depends on the right biochemical triggers being present at the right time. As we age, train harder, or push through injury, those signals weaken. BPC-157 steps in where the body's natural repair signalling falls short — amplifying the pathways responsible for tissue rebuilding, gut integrity, and structural recovery at a cellular level.

It's not a painkiller. It's not a band-aid. It's the difference between waiting for recovery and actively driving it.

Tendons and ligaments that actually recover

Most recovery products support comfort. BPC-157 supports the repair process itself. In rat models of Achilles tendon rupture, animals treated with BPC-157 showed significantly improved biomechanical outcomes — including greater failure load and tissue stiffness — within 10 to 14 days compared to untreated controls. Research has also shown BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts, directly supporting the cellular environment needed for structural repair. Mdorthospecialistsnih

Gut healing from the inside

BPC-157 is one of the few peptides with a meaningful research footprint in gastrointestinal models. Its origin — derived from a gastric protein — gives it a natural affinity for gut tissue, and the research reflects that. Studies have explored its role across gut integrity, mucosal repair, and inflammatory GI models, making it a practical option for anyone whose gut health is undermining their broader recovery or performance.

Acute injury support when you need it most

For higher-demand recovery periods — post-injury, post-procedure, or intensive training blocks — BPC-157 can be dosed more aggressively in the short term. Studies of muscle crush injuries demonstrated accelerated muscle fibre regeneration and repair of myotendinous junctions within one to two weeks, with less scar tissue formation. Its short half-life means twice-daily dosing keeps it consistently active throughout your recovery window. Mdorthospecialists

The research behind it

A 2025 systematic review covering 36 studies published between 1993 and 2024 found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models. A comprehensive review in Cell and Tissue Research found that all studies investigating BPC-157 demonstrated consistently positive and prompt healing effects across various injury types, concluding the peptide has significant potential for tendon, ligament, and skeletal muscle healing. Sage JournalsOath Research

Human evidence remains limited and ongoing, which is why BPC-157 is positioned as an investigational recovery peptide rather than a fully established clinical therapy. The preclinical signal, however, is among the most consistent of any recovery-focused peptide in the literature.

Ready to use. No mixing. No guesswork.

Supplied as a pre-mixed 5 mg / 2 mL cartridge, BPC-157 delivers precise, structured dosing with no reconstitution required. Every unit measures 25 mcg, so your protocol stays consistent from day one to your last dose.

Dosage Guide

Cycle guidance: 4–8 weeks for most protocols. Chronic injuries may benefit from up to 12 weeks.

5 mg / 2 mL · 2.5 mg/mL · 200 units per cartridge